Risedronate and blood lactate dehydrogenase increased Patient Reports February 12, 2012

Risedronate Side Effects Report #4629412-8
Risedronate side effect was reported by a Physician from on Mar 24, 2005. Female patient, 70 years of age, was diagnosed with spinal compression fracture and was treated with Risedronate. After drug was administered, patient experienced the following side effects: ascites, blood lactate dehydrogenase increased, cholelithiasis, colitis, colitis ulcerative, colonic stenosis, coxsackie viral infection, coxsackie virus serology test positive, erythema. Risedronate dosage: 2.5 MG DAILY, ORAL. During the same period patient was treated with ELCITONIN, VOLTAREN, ASPARA, AMOBAN, PURSENNID. Patient was hospitalized. Patient recovered.

Risedronate Side Effects Report #4882937-2
Risedronate side effect was reported by a Physician from JAPAN on Dec 27, 2006. Female patient, 87 years of age, was diagnosed with osteoporosis  and was treated with Risedronate. After drug was administered, patient experienced the following side effects: blood lactate dehydrogenase increased, cardiomegaly, creatine phosphokinase decreased, glucose urine, haematocrit decreased, haemoglobin decreased, lymphadenopathy, lymphocyte count decreased. Risedronate dosage: 2.5 MG DAILY, ORAL. During the same period patient was treated with CALCITRIOL, ELCITONIN. Patient was hospitalized. Patient recovered.

Risedronate Side Effects Report #5030741-7
Risedronate side effect was reported by a Physician from JAPAN on May 18, 2006. Female patient, 81 years of age, was diagnosed with osteoporosis  and was treated with Risedronate. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, bacterial infection , blood creatinine increased, blood lactate dehydrogenase increased, blood potassium increased, blood sodium decreased, blood urea increased, cardiac failure, haemoptysis. Risedronate dosage: 2.5 MG DAILY, ORAL. During the same period patient was treated with LOXONIN, CODEINE PHOSPHATE, HUSTAZOL, MAGNESIUM OXIDE, ULGUT, LEVOFLOXACIN. Patient was hospitalized. Patient died on 04/20/2006.

Risedronate Side Effects Report #5954623-9
Risedronate side effect was reported by a Physician from JAPAN on Oct 27, 2008. Female patient, 72 years of age, was diagnosed with osteoporosis  and was treated with Risedronate. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, ammonia increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, blood urea increased, gamma-glutamyltransferase increased, hepatic function abnormal, hypersensitivity. Risedronate dosage: 2.5 MG ONCE DAILY, ORAL. During the same period patient was treated with VOLTAREN. Patient was hospitalized. Patient recovered.


Risedronate Side Effects Report #4654066-4
Risedronate side effect was reported by a Physician from on Apr 19, 2005. Female patient, 62 years of age, was diagnosed with osteoporosis , nasopharyngitis and was treated with Risedronate. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, albumin globulin ratio decreased, aphasia , aspartate aminotransferase increased, blood alkaline phosphatase increased, blood cholesterol increased, blood cholinesterase increased, blood lactate dehydrogenase increased, depressed level of consciousness. Risedronate dosage: 2.5 MG ONCE, ORAL. During the same period patient was treated with LOXONIN. Patient was hospitalized. Patient recovered.

Risedronate Side Effects Report #5485937-7
Risedronate side effect was reported by a Physician from JAPAN on Sept 27, 2007. Male patient, 60 years of age, was diagnosed with osteoporosis  and was treated with Risedronate. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood lactate dehydrogenase increased, c-reactive protein increased, leukopenia, platelet count decreased, pyrexia, red blood cell count decreased. Risedronate dosage: 2.5 MG DAILY, ORAL. During the same period patient was treated with PREDNISONE, LORFENAMIN, MUCOSTA, SULFAMETHOXAZOLE, VITAMEDIN. Patient was hospitalized. Patient recovered.